Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IIIA Stage Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00673569
What this trial is testing

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Not applicableStudy completedNCT00310219
What this trial is testing

Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 52
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Large-scale testing (Phase 3)Ended earlyNCT02326285
What this trial is testing

Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB

Who this might be right for
Non-squamous Non-small Cell Lung Cancer Stage IINon-squamous Non-small Cell Lung Cancer Stage IIIANon-squamous Non-small Cell Lung Cancer Stage IIIB+2 more
AIO-Studien-gGmbH 1
Testing effectiveness (Phase 2)Study completedNCT00043108
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center 19
Large-scale testing (Phase 3)Active Not RecruitingNCT02193282
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaStage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7+3 more
National Cancer Institute (NCI) 390
Not applicableStudy completedNCT00305617
What this trial is testing

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Cleveland Clinic 10
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableNot Yet RecruitingNCT01595074
What this trial is testing

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Who this might be right for
Stage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 950
Large-scale testing (Phase 3)Study completedNCT00048997
What this trial is testing

Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 356
Testing effectiveness (Phase 2)Ended earlyNCT01342770
What this trial is testing

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 6
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Testing effectiveness (Phase 2)Looking for participantsNCT06918132
What this trial is testing

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+2 more
Mayo Clinic 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT01386385
What this trial is testing

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung AdenocarcinomaLung Adenocarcinoma, Mixed SubtypeLung Large Cell Carcinoma+5 more
National Cancer Institute (NCI) 53
Early research (Phase 1)Ended earlyNCT01912625
What this trial is testing

Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage III Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Active Not RecruitingNCT07180862
What this trial is testing

A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bio-Thera Solutions 160
Testing effectiveness (Phase 2)UnknownNCT03053856
What this trial is testing

Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Samsung Medical Center 37
Testing effectiveness (Phase 2)Study completedNCT00003231
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 40
Next Page